Invesco Ltd. Bluebird Bio, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 87,891 shares of BLUE stock, worth $38,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

87,891

Previous 81,772 7.48%

Holding current value

$38,672

Previous $104,000 17.31%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.85 - $1.26 $5,201 - $7,709	6,119 Added 7.48%	87,891 $86,000
Q1 2024 May 14, 2024	SELL	$0.91 - $1.75 $12,229 - $23,518	-13,439 Reduced 14.11%	81,772 $104,000
Q4 2023 Feb 12, 2024	BUY	$1.32 - $4.83 $8,339 - $30,515	6,318 Added 7.11%	95,211 $131,000
Q3 2023 Nov 13, 2023	BUY	$3.02 - $4.05 $474 - $635	157 Added 0.18%	88,893 $270,000
Q2 2023 Aug 11, 2023	BUY	$2.79 - $5.03 $5,939 - $10,708	2,129 Added 2.46%	88,736 $291,000
Q1 2023 May 12, 2023	SELL	$3.14 - $8.22 $2.27 Million - $5.95 Million	-724,228 Reduced 89.32%	86,607 $275,000
Q4 2022 Feb 13, 2023	SELL	$5.77 - $8.49 $4.08 Million - $6.01 Million	-707,844 Reduced 46.61%	810,835 $5.61 Million
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $4.99 Million - $9.84 Million	1,330,961 Added 709.02%	1,518,679 $9.61 Million
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $83,366 - $148,301	28,356 Added 17.79%	187,718 $777,000
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $341,135 - $888,460	83,817 Added 110.95%	159,362 $773,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $80,460 - $146,463	-8,980 Reduced 10.62%	75,545 $755,000
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $44,240 - $82,656	3,936 Added 4.88%	84,525 $1.62 Million
Q2 2021 Aug 17, 2021	SELL	$18.04 - $22.09 $68,642 - $84,052	-3,805 Reduced 4.51%	80,589 $2.58 Million
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $481,889 - $984,402	29,047 Added 52.48%	84,394 $2.55 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $581,047 - $801,211	21,129 Added 61.75%	55,347 $2.4 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $11,468 - $14,568	-333 Reduced 0.96%	34,218 $1.85 Million
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $93,428 - $158,366	-3,445 Reduced 9.07%	34,551 $2.11 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $2.55 Million - $6.19 Million	-97,442 Reduced 71.95%	37,996 $1.75 Million
Q4 2019 Feb 14, 2020	SELL	$46.96 - $61.67 $42.5 Million - $55.7 Million	-903,974 Reduced 86.97%	135,438 $11.9 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $864,099 - $1.35 Million	-14,530 Reduced 1.38%	1,039,412 $95.4 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $71.9 Million - $99.8 Million	948,400 Added 898.6%	1,053,942 $134 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $331,028 - $534,813	5,137 Added 5.12%	105,542 $16.6 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $5.93 Million - $9.36 Million	100,405 New	100,405 $9.96 Million

Others Institutions Holding BLUE

# of Institutions

158

Shares Held

79.9M

Call Options Held

525K

Put Options Held

634K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $33.9M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account